SRR1404969
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- KRAS_SIGNALING_DN+0.272
- DNA_REPAIR+0.093
- SPERMATOGENESIS+0.060
- MYC_TARGETS_V2+0.010
- PEROXISOME-0.031
- MYOGENESIS-0.059
- PANCREAS_BETA_CELLS-0.093
- APICAL_JUNCTION-0.104
- MITOTIC_SPINDLE-0.110
- MYC_TARGETS_V1-0.130
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.624
- TNFA_SIGNALING_VIA_NFKB-0.598
- INFLAMMATORY_RESPONSE-0.546
- INTERFERON_GAMMA_RESPONSE-0.527
- APOPTOSIS-0.512
- IL6_JAK_STAT3_SIGNALING-0.498
- TGF_BETA_SIGNALING-0.487
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.481
- ALLOGRAFT_REJECTION-0.451
- NOTCH_SIGNALING-0.448
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1474754 | GTEX | — | 0.990 |
| 2 | SRR1341605 | GTEX | — | 0.987 |
| 3 | SRR1456514 | GTEX | — | 0.987 |
| 4 | SRR1338669 | GTEX | — | 0.984 |
| 5 | SRR1459033 | GTEX | — | 0.983 |
| 6 | SRR1441200 | GTEX | — | 0.983 |
| 7 | SRR1419675 | GTEX | — | 0.981 |
| 8 | SRR1348770 | GTEX | — | 0.981 |
| 9 | SRR1377984 | GTEX | — | 0.980 |
| 10 | SRR1400375 | GTEX | — | 0.978 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 4 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.272 | Remibrutinib | — uncovered |
| DNA_REPAIR | 0.093 | Idelalisib | — uncovered |
| SPERMATOGENESIS | 0.060 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.010 | Idelalisib | — uncovered |